Company profile: Locust Walk
1.1 - Company Overview
Company description
- Provider of strategic partnering and M&A services, facilitating licensing and acquisition deals in the USA, Europe, Japan, and China. Offers capital raising and underwriting, including private placements, IPO advisory, and SPAC advisory. Delivers strategy consulting and analytics for partnering, M&A, and fundraising. Conducts rigorous due diligence via internal committee and external scientific advisory board.
Products and services
- Strategy Consulting and Analytics: Locust Walk architects analytics-driven corporate strategy, commercial assessment, and transaction planning to drive effective partnering, M&A, and fundraising execution across deal preparation and decision-making
- Strategic Partnering and M&A Transactions: Locust Walk delivers global-scale licensing and acquisition processes by positioning assets and companies and executing comprehensive outreach-to-close strategic workflows across the USA, Europe, Japan, and China
- Capital Raising and Underwriting: Locust Walk produces capital-market fundraising programs by preparing and executing private placements and public financings, including IPO advisory, SPAC advisory, and underwriting services to help companies raise capital
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Locust Walk
Avenacy
HQ: United States
Website
- Description: Provider of critical injectable pharmaceuticals, manufacturing generic and therapeutic equivalents including eptifibatide (generic Integrilin) for acute coronary syndrome, bivalirudin (generic Angiomax), fosaprepitant, fulvestrant in prefilled syringe kits, and desmopressin acetate, offered in sterile single-dose vials, multi-dose vials, and sterile powder formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avenacy company profile →
Primrose Bio
HQ: United States
Website
- Description: Provider of biotechnology solutions for discovery, development, and manufacturing of new molecules, including Pfenex Expression Technology for high-yield production of complex proteins, Prima RNApols to enhance mRNA yield and quality, PeliCRM197 carrier protein for conjugate vaccines, the Function Generator for novel gene creation, and EOS for enzymatic DNA/RNA oligonucleotide synthesis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primrose Bio company profile →
Curapath
HQ: Spain
Website
- Description: Provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curapath company profile →
ProQinase
HQ: Germany
Website
- Description: Provider of contract research services, founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg. Originated to support the center’s in-house anti-cancer drug development by marketing research tools, with roots in a cancer center that combined research and patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProQinase company profile →
Summit Clinical Research
HQ: United States
Website
- Description: Provider of integrated non-alcoholic steatohepatitis (NASH) clinical research services, including site selection for top-enrolling trial sites and expedited start-up; site-specific pre-screening and enrollment strategies with branded recruitment; key opinion leader guidance and training; education, evidence generation, data dissemination and digital solutions; network site collaboration and support; and a Cirrhosis Advisory Board.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Summit Clinical Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Locust Walk
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Locust Walk
2.2 - Growth funds investing in similar companies to Locust Walk
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Locust Walk
4.2 - Public trading comparable groups for Locust Walk
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →